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We report a male patient with developmental delay carrying an interstitial 4p16.3 deletion of 287 kb, disclosed by
oligo array-CGH and inherited from his father with a similar but milder phenotype. This deletion is distal to the
Wolf-Hirschhorn syndrome critical regions, but includes the FGFRL1 gene proposed to be a plausible candidate for
part of the craniofacial characteristics of Wolf-Hirschhorn syndrome patients. However, the proband lacks the typical
facial appearance of the syndrome, but exhibits overgrowth, dysfunction of temporomandibular articulation and a
bicuspid aortic valve. Given the pattern of expression of the fibroblast growth factor receptor-like 1 and its involvement
in bone and cartilage formation as well as in heart valve morphogenesis, we discuss the impact of its haploinsufficiency
in the phenotype.
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Wolf-Hirschhorn syndrome (WHS; OMIM#194190) is a
contiguous gene syndrome caused by deletion of the
short arm of chromosome 4. There is a considerable
variation in the phenotypic spectrum and a correlation
between the size of the deletion and severity of the
phenotype has been recognized [1]. Two Wolf-Hirschhorn
critical regions, WHCR1 and WHCR2, have been identi-
fied within 4p16.3 [2,3]. Beyond this region, the loss of
additional critical genes appears to be responsible for
variable present features, the identification of patients with
distal 4p deletions could help to identify for pathogenic
genes that may be involved in components of the WHS
phenotype.
Here we report a patient with a mild phenotype carrying
an interstitial 287 kb deletion at 4p16.3, distal to the al-
ready described WHS critical regions, and encompassing* Correspondence: i_marques@hotmail.com
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unless otherwise stated.FGFRL1 gene proposed to be involved in the craniofacial
characteristics. We discuss the involvement of this gene in
the features displayed by the patient and compare with
other patients reported with overlapping imbalances.Case presentation
Clinical report
The 11-years-old male proband is the first child of
unrelated parents. He was born at 38 weeks of gestation
after uneventful pregnancy. His weight was 3900 g (90th
percentile), length of 51 cm (50th percentile), and occipi-
tofrontal circumference (OFC) of 36 cm (75th percentile).
Apgar scores were 9 and 10 at 1 and 5 minutes, respect-
ively. He started to talk and walk independently at 2 years
of age. It was noted to have difficulties in language skills,
so he has been having language therapy since the age of 3.
At 6 years he started to have pedo-psychiatric support. At
the age of 11 years he was referred to genetics evaluation
after diagnosis of bicuspid aortic valve in routine echocar-
diography. On physical examination, the patient showed
overgrowth with a weight of 51,5 kg (95th percentile),
height of 168 cm (>95th percentile), and OFC of 53,5 cm
(50th-75th percentiles). Craniofacial findings included an
asymmetric long face, with retrognathia, short philtrumLtd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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of temporomandibular articulation, long prominent nose
and prominent ears (Figure 1b). The hands have long fin-
gers (Figure 1c), the feet display bilateral sandal gap of the
first toes with large halluces (Figure 1d). Because of the
developmental delay and overgrowth, homocysteine levels
were investigated but showed a normal result. Electro-
encephalogram was normal, but MRI of the brain revealed
a slight diminish of the frontal lobe mainly on the right
side. Although in orthopedic examination he didn’t reveal
any remarkable alterations, he has a postural kyphosis
with sloping shoulders (Figure 1e) and asymmetric pos-
ition of scapulas. He has a mild global cognitive impair-
ment, but a more pronounced dysfunction in expressive
language and articulation of speech.
His father has similar but milder phenotypic features
and had strong learning difficulties at school, also
with limitations in language articulation. He exhibits
a tall stature, the facial appearance displays a slight asym-
metry with a long prominent nose, short philtrum and ret-
rognathia. Neither the patient nor his father have had
seizures.
In the father’s family there is a history of remarkable
delay in his sister, brothers and nephews with learning
difficulties. Unfortunately, it was not possible to evaluate
any other of the affected family members.
The proband had already normal investigation results
of conventional cytogenetics analysis, fragile-X syndrome
testing and subtelomeric screening.Figure 1 Phenotypic characteristics of the patient at 14 years of age.
and prominent nose, large or prominent ears, (c) hands with long fingers,
postural kyphosis with sloping shoulders.Methods
High-resolution comparative genomic hybridization (array-
CGH) analysis was performed using Agilent SurePrint G3
Human Genome microarray 180 K (Agilent Technologies,
Santa Clara, CA), an oligonucleotide microarray contain-
ing approximately 180,000 sixty-mer probes with a 17 kb
average probe spacing, as described before [4]. In order to
confirm the array-CGH result, MLPA (MRC Holland,
Amsterdam, Netherlands) using the set of probes P373,
was performed according to the manufacturers’ instruc-
tions. The study of the parents was done with the same
MLPA probemix.
Results
The oligo array-CGH showed an interstitial deletion
at 4p16.3 spanning about 287 kb of genomic DNA
from position 927,780 bp (clone A_16_P16565674) to
1,214,915 bp (clone A_16_P00907084) flanked by
probe A_16_P00906727 (920,051 bp) and probe A_18_
P23419088 (1,228,462 bp) according to UCSC Genome
Browser (hg19; GRChBuild 37.1, February 2009) (Figure 2).
The deleted segment contains 11 RefSeq genes, 7 genes
are described in the OMIM database: DGKQ (#601207) a
diacylglycerol kinase, SLC26A1 (# 610130) a sulfate anion
transporter 1, IDUA (# 252800) a alpha-L-iduronidase
(associated to a lysosomal storage disease by homozygous
or compound heterozygous mutation), FGFRL1 (#605830)
the fibroblast growth factor receptor-like 1, RNF212
(#612041) a ring finger protein that plays a role in meiotic(a) Asymmetric long face, with retrognathia and short philtrum, (b) long
(d) bilateral sandal gap of the first toes with large halluces, (e)
Figure 2 Genomic region of 4p16.3 involved in the deletions of patients with distal imbalances to WHS critical regions (adapted from
UCSC genome browser, GRCh37/hg19), displaying the RefSeq genes. A comparison of the extension of the deletions with previously
reported patients is also shown.
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(#602618) the C-terminal-binding protein 1.
MLPA confirmed the array result with two probes for
genes SPON2 and FGFRL1. Parental testing was performed
with MLPA, showing the father to be carrier of the same
imbalance.
Discussion
We report a patient with an interstitial deletion on
4p16.3, inherited from the father, this deletion is distal
to de WHS critical regions. However, this imbalance en-
compasses the fibroblast growth factor receptor-like 1
(FGFRL1) gene proposed to be an important candidate
contributing to the craniofacial phenotype [5,6]. The
patient described lacks the typical facial features of the
WHS, only exhibiting prominent nose and short phil-
trum. This gene has also been associated with intrauterine
growth retardation and postnatal short stature in WHS
patients [7], opposite to the finding in our patient that
displays overgrowth since the neonatal period. Delayed in
speech is a frequent problem in patients with 4p16.3
deletions [8], even among patients with non overlapping
imbalances. Probably more than one gene contributes to
the language impairment, that in the proband and his
father could be associated with the dysfunction of the
temporomandibular articulation.
FGFRL1 inhibits cell proliferation, but promotes cell
differentiation and induces cell adhesion (involved in
cell-cell fusion), it is primarily expressed in cartilaginous
tissues and in bone primordia (like the maxillae, the
mandibles, the ribs and the nose), the muscles of the
tongue and the diaphragm express FGRFL1 at a relativelyhigh level, but the heart, aorta, skeletal muscle, brain,
lung, liver, kidney and gut it is expressed at a moderate
level [9]. Taking into account its function and pattern of
expression, the haploinsufficiency of FGFRL1 could be
associated with the craniofacial phenotype of proband
including the dysfunction of temporomandibular articula-
tion and the overgrowth could be a consequence of the
partial lack of the negative effect of FGFRL1 in cell pro-
liferation particularly in bone tissues. However, in the
research work of Catela et al. [6] with an Fgfrl1−/− null
mice, an animal model to dissect the aetiology of WHS, as
far as we know overgrowth has never been detected, only
short stature is described in mutants that develop to term,
but most homozygous embryos suffer prenatal death.
Since the heterozygous mutant Fgfrl1+/− did not display a
discernible phenotype [6], these contradictory results are
difficult to interpret. Probably in humans the haploinsuffi-
ciency of other neighbouring genes plays a critical role in
the physiological impact of FGFRL1 heterozygous deletion.
The presence of cardiac defects is observed in some pa-
tients with WHS [7], but a patient described by Okamoto
et al. [10], with a small deletion encompassing WHSC1 but
not including the FGFRL1, didn’t exhibit cardiac malfor-
mation. On the other hand, in the report of South et al.
[11] the echocardiogram of both patients didn’t reveal any
alteration although the deletions involved include the
FGFRL1 gene. In the patient described the presence of a
bicuspid aortic valve could be a coincidental finding or
maybe suggests the contribution of FGFRL1 in heart valvu-
logenesis. This observation is supported by the experimen-
tal results with the Fgfrl1−/− null mice, suggesting a role for
Fgfrl1 in valvulogenesis and ventricular septation [6].
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ation between the genes involved in different deletions
within 4p16.3 and the craniofacial phenotype is done.
One of the patients was reported by Faravelli et al. [13],
mother of the propositus, she carries a terminal deletion
distal to both critical regions of WHS, but including
FGFRL1, her facial features included hypertelorism, high
nasal bridge, down-slanting of palpebral fissures and
large protruding eyes, but our patient with a smaller
deletion also harbouring FGFRL1 doesn’t display neither
of these characteristics. South et al. [11] described two
patients with 4p terminal deletions distal to WHS critical
regions but including FGFRL1 and a portion of LETM1 in
one of them (Figure 2), they didn’t exhibit the typical facial
features of the syndrome, but have prominent forehead,
mild telecanthus and normal philtral length, in both it was
observed growth delay and mild developmental delay. On
the other hand the patient reported by Engbers et al. [5]
with a 1.6 Mb deletion have typical facial signs of the
WHS, this deletion includes FGFRL1 but also other prox-
imal genes that could be involved in the displayed pheno-
type (Figure 2). Our report supports the hypothesis that
multiple genes are involved in the orchestration, not only
of the facial phenotypic features but in the other malfor-
mations and cognitive skills observed in WHS patients in
a contiguous manner. As it was confirmed in the study of
Maas et al. [7], of a cohort of patients with different size
deletions and genotype-phenotype correlation, several
clinical features of WHS have considerable variable ex-
pressivity or penetrance, so it is difficult to pinpoint the
genes involved in the more rare aspects of the WHS
phenotype. The identification of distal 4p deletions cov-
ering about 0.4-0.5 Mb in individuals without a patho-
genic phenotype suggests that monosomy of this region
is likely benign [14,15]. But deletions extending to the
1.4 Mb region appear to be pathogenic (Figure 2),
although with a mild phenotype [7,11,13] and no typical
facial appearance of WHS. Deletions extending to 1.6 Mb
can however display some overlapping features to the
phenotype of WHS [5], suggesting the presence of other
genes contributing to the displayed features.
Conclusions
The present report could help to unravel the phenotypic
manifestations underlying the haploinsufficiency of the
FGFRL1 gene. Its involvement in the bone primordia
formation and in heart morphogenesis has been described
even in animal models [6]. However, the observation of a
tall stature in the proband and his father is a specific find-
ing of this report. A better characterization of patients
with atypical and smaller interstitial deletions could con-
tribute to the knowledge of the biological function of
neighbouring genes out of the core critical regions of
the WHS.Consent
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